Aurinia Pharmaceuticals Inc

AUPH NASDAQ Healthcare & Biotech United States CA05156V1022
16.96 $
5.15 %

Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on developing innovative therapies to treat autoimmune diseases.